---
title: "MD SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Pediatrix Medical (MD), with links to the SEC filings."
url: "https://tradytics.com/research/MD/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=MD&v=stock-11994873"
---

# MD financial statements and SEC filings

## MD annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $1.91B | $208.81M | $165.39M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000119312526058074/0001193125-26-058074-index.htm) |
| 2024-12-31 | $2.01B | -$68.71M | -$99.07M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000119312526058074/0001193125-26-058074-index.htm) |
| 2023-12-31 | $1.99B | $7.32M | -$60.41M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000119312526058074/0001193125-26-058074-index.htm) |
| 2022-12-31 | $1.97B | $172.69M | $66.33M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000095017025023730/0000950170-25-023730-index.htm) |
| 2021-12-31 | $1.91B | $202.92M | $130.96M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000095017024016794/0000950170-24-016794-index.htm) |
| 2020-12-31 | $1.73B | $98.13M | -$796.49M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000095017023003127/0000950170-23-003127-index.htm) |

## MD annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $2.25B | $1.38B | $865.85M | [10-Q](https://www.sec.gov/Archives/edgar/data/893949/000119312526436952/0001193125-26-436952-index.htm) |
| 2024-12-31 | $2.15B | $1.39B | $764.94M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000119312526058074/0001193125-26-058074-index.htm) |
| 2023-12-31 | $2.22B | $1.37B | $849.06M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000095017025023730/0000950170-25-023730-index.htm) |
| 2022-12-31 | $2.35B | $1.46B | $891.63M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000095017024016794/0000950170-24-016794-index.htm) |
| 2021-12-31 | $2.72B | $1.83B | $896.69M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000095017023003127/0000950170-23-003127-index.htm) |
| 2020-12-31 | $3.35B | $2.60B | $747.72M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000095017022001387/0000950170-22-001387-index.htm) |

## MD annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $271.09M | -$18.46M | -$107.49M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000119312526058074/0001193125-26-058074-index.htm) |
| 2024-12-31 | $206.57M | -$22.02M | -$14.48M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000119312526058074/0001193125-26-058074-index.htm) |
| 2023-12-31 | $137.32M | -$33.33M | -$25.71M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000119312526058074/0001193125-26-058074-index.htm) |
| 2022-12-31 | $166.94M | -$29.71M | -$487.55M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000095017025023730/0000950170-25-023730-index.htm) |
| 2021-12-31 | $76.74M | -$32.25M | -$760.12M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000095017024016794/0000950170-24-016794-index.htm) |
| 2020-12-31 | $204.62M | -$28.79M | -$4.16M | [10-K](https://www.sec.gov/Archives/edgar/data/893949/000095017023003127/0000950170-23-003127-index.htm) |

- [MD stock research](https://tradytics.com/research/MD)
- [MD financial summary](https://tradytics.com/research/MD/financials)
- [Read the data without JavaScript](https://tradytics.com/research/MD/fundamentals?snapshot=1)
